Risk stratification in PAH: are any of our patients really "low risk"?
Event:
ESC Congress 2017
Congress Presentation
About the speaker
Professor Irene Marthe Lang
Medical University of Vienna, Vienna (Austria)
33
presentations
5
followers
4 more presentations in this session
Introduction - Can you achieve more for your pulmonary arterial hypertension (PAH) patients? An expert review of key recent data with initial combination therapy.
Speaker: Professor I. Lang (Vienna, AT)
The importance of reducing hospitalisations in PAH.
Speaker: Professor J. Vachiery (Brussels, BE)
Can your connective tissue disease-associated PAH patients achieve similar outcomes to your idiopathic PAH patients?
Speaker: Doctor J. Coghlan (London, GB)
Q&A - Can you achieve more for your PAH patients? An expert review of key recent data with initial combination therapy.
Speaker: Professor I. Lang (Vienna, AT)
Access the full session
Can you achieve more for your pulmonary arterial hypertension (PAH) patients? An expert review of key recent data with initial combination therapy
Speakers:
Professor I. Lang, Professor I. Lang, Professor J. Vachiery, Doctor J. Coghlan, Professor I. Lang
About the event
ESC 365 is supported by
